reference/23068464

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23068464

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	2004
issn	0007-0920 1532-1827
issueIdentifier	12
pageRange	1996-2004
publicationName	British Journal of Cancer
startingPage	1996
bibliographicCitation	Gridelli C, Gallo C, Di Maio M, Barletta E, Illiano A, Maione P, Salvagni S, Piantedosi FV, Palazzolo G, Caffo O, Ceribelli A, Falcone A, Mazzanti P, Brancaccio L, Capuano MA, Isa L, Barbera S, Perrone F. A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study. British Journal of Cancer. 2004 Nov 23;91(12):1996–2004. doi: 10.1038/sj.bjc.6602241.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d76bc9137ea65f0946da505e2a4f8b25 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8871b3142939fef4b76fd18eef7f8bcb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d401a747d72bef51916b47f65a8d307 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54174876b99b7a0b6a46cc9a5b8ca22a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_272414c6b7222ff34d4311ea92a9e9db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_732bdff5b2306cc30d8bec2f64ba6f0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3b18d187eefbfd1b20e852d2cb4d336 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_362c8863954a24101156d6cef22ef37f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_643addaebc80f297381213fa9c9f024c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bbcbb05ebb03a0d3f9bac60cac51afc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_702508c8791b35e61ba1b351e8032cf9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fdec50bcd49aabb7e3c451d3b6cf062 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84fc76ca890f91736f6c120ce707fa2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb8aab098feecce4908ad81f156c5c40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3618f2a7f8d5852f202a1590b89867f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28da9396e4077ecf79203b8897f1b01e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c851a904dee2101e382f55df65733321 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a47f037cb8a9df08d9a87a64be245c8
date	2004-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2409790 https://pubmed.ncbi.nlm.nih.gov/15558071 https://doi.org/10.1038/sj.bjc.6602241
isPartOf	https://portal.issn.org/resource/ISSN/1532-1827 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765 https://portal.issn.org/resource/ISSN/0007-0920
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
discusses	http://id.nlm.nih.gov/mesh/M0001486 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0443608
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D043823Q000008 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D000972Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D043823Q000009 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D000972Q000009 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6847 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6910 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7353 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7507 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861

Total number of triples: 82.